| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/21/2007 | US20070142459 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 06/21/2007 | US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 06/21/2007 | US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142338 Tetracycline Derivatives and Methods of Use Thereof |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142312 Antigen delivery system |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070142280 Factor VII or VIIa-like molecules |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070141620 Producing polyoxyethylene glycol covalently bound to human interferon; antiinflammatory and antitumor agents; autoimmune diseases and infections; conjugation decreases the number of doses for an intended effect, simplify and stabilize the formulation of a composition |
| 06/21/2007 | US20070141162 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 06/21/2007 | US20070141088 Glucan-based vaccines |
| 06/21/2007 | US20070141087 Compounds and methods for diagnosis of tuberculosis |
| 06/21/2007 | US20070141085 Recombinant protective protein from Streptococcus pneumoniae |
| 06/21/2007 | US20070141081 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
| 06/21/2007 | US20070141078 Monovalent; low dose of egg-derived influenza virus antigen from an influenza virus strain associated with or having the potential to cause a pandemic outbreak (e.g. H5N1antigen), with an oil in water emulsion adjuvant of an oil, alpha-tocopherol, and an emulsifier; can be made quickly in pandemic |
| 06/21/2007 | US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 06/21/2007 | US20070140987 Promoting whole body health |
| 06/21/2007 | DE202007003020U1 Zusammensetzung als Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel oder Wundmittel Composition as pharmaceuticals, disinfectants, care and hygiene products or wound means |
| 06/21/2007 | DE102005060920A1 Peptide für die Wechselwirkung mit alpha-helikalen Coiled-Coil-Strukturen und/oder Coiled-Coil-Sequenzen, davon abgeleitete Mittel und ihre Verwendung Peptides for interaction with alpha-helical coiled-coil structures and / or the coiled-coil sequences derived therefrom and their use |
| 06/21/2007 | CA2667091A1 Method for correcting a lipid imbalance in a subject |
| 06/21/2007 | CA2635717A1 Crystalline forms of 1-benzoyl-4-[2[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 06/21/2007 | CA2633603A1 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
| 06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633417A1 Diaryl ureas for treating virus infections |
| 06/21/2007 | CA2633400A1 Diaryl urea for treating virus infections |
| 06/20/2007 | EP1798285A1 Methods and medicament for inhibition the expression of a defined gene |
| 06/20/2007 | EP1798231A2 Intermediate products for the preparation of antibacterial compounds |
| 06/20/2007 | EP1797896A1 Adjuvant systems and vaccines |
| 06/20/2007 | EP1797894A2 Vaccine composition |
| 06/20/2007 | EP1797892A1 Use of modified cyclosporins for the treatment of HCV disorders |
| 06/20/2007 | EP1797879A1 Novel antimicrobial medicine |
| 06/20/2007 | EP1797866A2 Oral hygiene formulations in the form of capsules |
| 06/20/2007 | EP1797171A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
| 06/20/2007 | EP1797125A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 06/20/2007 | EP1797111A1 Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/20/2007 | EP1797087A1 Carbo- and hetero-cyclic antibiotics and use thereof |
| 06/20/2007 | EP1797062A1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| 06/20/2007 | EP1797050A1 Hiv inhibiting 1.2.4-triazin-6-one derivates |
| 06/20/2007 | EP1797047A1 Hiv inhibiting 5-substituted pyrimidines |
| 06/20/2007 | EP1796662A2 Inhibition of viruses using rnase h inhibitors |
| 06/20/2007 | EP1796647A2 Stable pegylated interferon formulation |
| 06/20/2007 | EP1517687B1 Medicament for the treatment of the systemic inflammatory response syndrome |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1228231B1 Mammalian-type glycosylation in plants |
| 06/20/2007 | EP1179010B1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 06/20/2007 | EP1159405B1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | CN1984918A Ketolide antibacterials |
| 06/20/2007 | CN1984917A HIV integrase inhibitors: cyclic pyrimidinone compounds |
| 06/20/2007 | CN1984908A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 06/20/2007 | CN1984674A Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 06/20/2007 | CN1984671A Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (HCV) |
| 06/20/2007 | CN1984654A Combination of anti-HIV reverse transcriptase and protease inhibitors |
| 06/20/2007 | CN1982456A China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
| 06/20/2007 | CN1982331A Recombinant thymus pentapeptide structural analogs, its production and use |
| 06/20/2007 | CN1982330A Methods for preparing purified lipopeptides |
| 06/20/2007 | CN1982306A Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity |
| 06/20/2007 | CN1982304A Flavane compound |
| 06/20/2007 | CN1982303A Water soluble anti-HIV component of lithospermum erythrorhizon and its extracts |
| 06/20/2007 | CN1981871A Elemene externally-applied preparation and its use |
| 06/20/2007 | CN1981867A Specific effervescent tablet against candida albicans IgY |
| 06/20/2007 | CN1981866A DC vaccine for treating chronic hepatitis B |
| 06/20/2007 | CN1981862A Foot nursing cream and its production |
| 06/20/2007 | CN1981833A Medicinal composition of elutriate, virgate wormwood herb and and cape-jasmine |
| 06/20/2007 | CN1981832A Use of cape-jasmine extract in treatment of chronic hepatitis B |
| 06/20/2007 | CN1981828A Production of uterus perfusion |
| 06/20/2007 | CN1981815A Hand and foot antibacterial detergent and its production |
| 06/20/2007 | CN1981812A Chinese-medicinal preparation for treating AIDS and its production |
| 06/20/2007 | CN1981808A Chinese medicine for treating avian influenza |
| 06/20/2007 | CN1981807A Medicinal composition for preventing and treating hepatitis and hepatocarcinoma and its production |
| 06/20/2007 | CN1981804A Production and usage for largeleaf liver soft capsules |
| 06/20/2007 | CN1981792A Production of Dogbane leaf extract, its medicinal preparation and usage in treatment of liver diseases |
| 06/20/2007 | CN1981791A Antibacterial liquid for killing sperma and virus fastly |
| 06/20/2007 | CN1981784A Chinese caterpillar fungus capsules |
| 06/20/2007 | CN1981781A Bear-ball total bound cholic acid injection, its production and usage |
| 06/20/2007 | CN1981780A Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/20/2007 | CN1981779A Xanthosine composition and its production |
| 06/20/2007 | CN1981771A Ointement for treating ringworm |
| 06/20/2007 | CN1981770A Olea acid dropping balls and their production |
| 06/20/2007 | CN1981765A Medicament composition of cefpodoxime proxetil and cyclodextrin and preparation method thereof |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981738A Stomach resorting agent of cephalosporin and preparation method thereof |
| 06/20/2007 | CN1322134C Expression system |
| 06/20/2007 | CN1322127C BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 06/20/2007 | CN1322120C Bivalent hepatitis B-encephalitis B vaccine |
| 06/20/2007 | CN1322119C Mandarin fish rhabdo virus toxic strain, its preparation method and application |
| 06/20/2007 | CN1322114C Anti-tumor and antiviral medicine and production method thereof |
| 06/20/2007 | CN1322014C Gecko polysaccharide, and its preparing method and pharmaceutical use |
| 06/20/2007 | CN1322009C Monoclonal antibody of virus receptor of anti leukoplakia disease and preparation method |
| 06/20/2007 | CN1322008C Monoclonal antibody of anti lymphocyst virus of and preparation method |
| 06/20/2007 | CN1322007C Antibacterial peptide DC and its preparing process and use |
| 06/20/2007 | CN1321997C Application of stable thiabutyldine quinoline carboxylate in preparing anti-infective |